ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Edelson to Direct Yale Cancer Center (12-page issue).

May 30, 2003

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady Wins RSNA Medal

January 5, 1990

Also: CALGB elects Schilsky to third term as chairman.

July 16, 2004

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

March 26, 2010